Traders' overwhelming 96.4% implied probability for an 80–90 flu hospitalization rate per 100,000 population in Week 11 (late February 2026) stems from CDC historical data, where moderate-to-high severity seasons typically accumulate 70–100 cumulative hospitalizations by that point, as seen in 2022–23 (110+) and 2017–18 (90+). Recent 2024–25 FluView trends show elevated activity with H3N2 dominance and vaccination effectiveness around 40–50%, aligning with post-pandemic normalization of flu burdens after the anomalously low 2020–21 season. This positioning could shift if early-season vaccination uptake surges beyond 50%, a novel low-virulence strain emerges, or public health measures like masking rebound amid concurrent RSV/COVID surges, potentially capping rates below 70.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jourFlu Hospitalization Rate Week 11, 2026?
Flu Hospitalization Rate Week 11, 2026?
80–90 96.4%
70–80 1.7%
90–100 1.0%
60–70 <1%
$15,079 Vol.
$15,079 Vol.
<60
<1%
60–70
1%
70–80
2%
80–90
96%
90–100
1%
100+
<1%
80–90 96.4%
70–80 1.7%
90–100 1.0%
60–70 <1%
$15,079 Vol.
$15,079 Vol.
<60
<1%
60–70
1%
70–80
2%
80–90
96%
90–100
1%
100+
<1%
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Marché ouvert : Mar 20, 2026, 2:29 PM ET
Resolver
0x69c47De9D...Resolver
0x69c47De9D...Traders' overwhelming 96.4% implied probability for an 80–90 flu hospitalization rate per 100,000 population in Week 11 (late February 2026) stems from CDC historical data, where moderate-to-high severity seasons typically accumulate 70–100 cumulative hospitalizations by that point, as seen in 2022–23 (110+) and 2017–18 (90+). Recent 2024–25 FluView trends show elevated activity with H3N2 dominance and vaccination effectiveness around 40–50%, aligning with post-pandemic normalization of flu burdens after the anomalously low 2020–21 season. This positioning could shift if early-season vaccination uptake surges beyond 50%, a novel low-virulence strain emerges, or public health measures like masking rebound amid concurrent RSV/COVID surges, potentially capping rates below 70.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes